BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12

• Press Releases

  Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003

  June 2, 2026

   · 

  4 min read
• Press Releases

  Ollin Biosciences Announces Upcoming Presentations of 20-week Data from Randomized Head-to-Head Study of OLN324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration at Clinical Trials at the Summit 2026

  June 2, 2026

   · 

  2 min read
• Press Releases

  Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes

  June 2, 2026

   · 

  8 min read
• Press Releases

  TearSolutions Receives FDA Orphan Drug and Fast Track Designations for Lacripep® in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed

  June 2, 2026

   · 

  2 min read
• Press Releases

  Contraline Announces $92.5 Million Series B Financing to Advance NES/T Male Contraceptive into Late-Stage Development

  June 2, 2026

   · 

  3 min read
• Press Releases

  Inipharm Initiates Dosing in 12-Week Proof-of-Concept Clinical Study in MASH With Its Oral HSD17B13 Inhibitor INI-822

  June 2, 2026

   · 

  3 min read
• Press Releases

  Alliance Clinical Network and Atlas Clinical Research Announce Strategic Merger

  June 2, 2026

   · 

  3 min read
• Press Releases

  Cencora to Support U.S. Distribution of Kite’s CAR T-Cell Therapies

  June 2, 2026

   · 

  2 min read
• Press Releases

  Phosphorex Names John Rigg Chairman of the Board

  June 2, 2026

   · 

  2 min read
• Press Releases

  Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Patients with Triple-Negative Breast Cancer and Esophageal Squamous Cell Carcinoma

  June 2, 2026

   · 

  10 min read